Deals

LeMaitre Vascular Closes $10M CMPO at 8% Discount via Cannaccord, Stifel

By |

LeMaitre Vascular, Inc. (LMAT) announced that it has raised $10,010,000 in a CMPO/Overnight transaction. The common stock was sold at $7.00 per share, an approximate 8% discount to the market price ($7.63) of LMAT at deal announcement. Canaccord Genuity Inc. (US) and Stifel Nicolaus Weisel acted as Joint Book-Running Managers and Roth Capital Partners, LLC, Barrington Research Associates, Inc., Benchmark Company, LLC, and Brean Capital, LLC acted as Co-Managers on the transaction. Placement Agent counsel was Choate, Hall & Stewart, LLP and issuer counsel was Cooley LLP. The transaction is expected to close on 06/04/2014.

Deals

Catasys Raises $1.5M at 61% Discount via Chardan Capital

By |

Catasys Inc. (CATS) announced that it has raised $1,500,002 in a Common Stock transaction. The common stock was sold at $0.58 per share, an approximate 61% discount to the market price ($1.50) of CATS at deal announcement. A series of 2,586,210 60-Month Warrants with an exercise price of $0.58 per share (61.33% discount) was issued to the investors in this transaction. Chardan Capital Markets acted as the exclusive agent on the transaction. The investors included Crede CG III, Limited and Shamus, LLC.

Deals

Retrophin Raises $40M in Equity-linked Debt from Athyrium Capital

By |

Retrophin, Inc. (RTRX) announced that it has raised $40,000,000 in a Non-Convertible Term Notes transaction. Barclays Capital, Inc. acted as the exclusive agent on the transaction. The investor was Athyrium Capital Management, LLC. This Placement is part of a $80 million financing. The other $40 million was funded in the form of Convertible Notes.